Cytovance Biologics Launches Cell Banking And Storage Practice

CHICAGO--(BUSINESS WIRE)--April 12, 2006--Cytovance® Biologics today announced the launch of a cGMP-compliant cell banking and storage practice for mammalian cell lines in support of the rapid development and cGMP production of antibody and recombinant protein products. The company's cell banking practice operates from 6,000 sq. ft. of newly acquired cleanrooms located adjacent to Cytovance's existing process development laboratories and custom-designed multi-product primary cGMP production facility.